Skip to main content
. Author manuscript; available in PMC: 2020 Sep 16.
Published in final edited form as: Environ Int. 2020 Jun 25;142:105892. doi: 10.1016/j.envint.2020.105892

Table 3.

Adjusted ORs for BASC-2 and CBCL scores in the borderline or clinical range for each 1-unit increase in unadjusted prenatal phthalate concentration quartiles for low molecular weight phthalates (i.e., MBP, MiBP, MEP, MMP, ΣLMWP).

MBPa
OR (95% CI)
MiBPa
OR (95% CI)
MEPa
OR (95% CI)
MMPa
OR (95% CI)
ΣLMWPb
OR (95% CI)
BASC-2
Externalizing Problems 1.33 (0.82, 2.15) 1.39 (0.83, 2.32) 1.34 (0.89, 2.02) 1.09 (0.71, 1.68) 1.36 (0.89, 2.08)
Internalizing Problems 1.46 (0.99, 2.14) 1.93*** (1.25, 3.00) 1.13 (0.81, 1.57) 1.12 (0.80, 1.57) 1.32 (0.92, 1.87)
BSI 1.45 (0.94, 2.24) 1.59 (0.99, 2.55) 1.09 (0.76, 1.58) 1.23 (0.83, 1.83) 1.14 (0.78, 1.67)
Hyperactivity 1.33 (0.89, 1.98) 1.18 (0.77, 1.82) 1.13 (0.81, 1.58) 0.99 (0.69, 1.42) 1.16 (0.82, 1.65)
Aggression 1.21 (0.77, 1.90) 1.78** (1.10, 2.88) 1.02 (0.71, 1.47) 1.16 (0.78, 1.72) 1.12 (0.76, 1.65)
Anxiety 1.37* (1.00, 1.88) 1.47* (1.03, 2.11) 0.96 (0.73, 1.26) 1.17 (0.88, 1.56) 1.10 (0.82, 1.46)
Depression 1.04 (0.70, 1.56) 1.78** (1.14, 2.79) 1.11 (0.79, 1.56) 0.96 (0.68, 1.36) 1.31 (0.91, 1.88)
Somatization 1.43 (0.85, 2.41) 1.73 (0.95, 3.14) 1.04 (0.67, 1.64) 0.95 (0.60, 1.50) 1.09 (0.67, 1.78)
Atypicality 1.11 (0.80, 1.54) 1.25 (0.87, 1.80) 0.98 (0.75, 1.30) 1.09 (0.82, 1.46) 0.94 (0.70, 1.27)
Withdrawal 1.14 (0.76, 1.71) 1.28 (0.82, 2.00) 1.19 (0.85, 1.68) 1.03 (0.73, 1.47) 1.09 (0.76, 1.58)
Attention Problems 1.30 (0.88, 1.93) 1.27 (0.83, 1.94) 1.10 (0.79, 1.53) 0.97 (0.68, 1.37) 1.12 (0.79, 1.58)
CBCL
Externalizing Problems 1.45 (0.95, 2.21) 1.47 (0.93, 2.32) 1.33 (0.93, 1.91) 1.18 (0.81, 1.72) 1.34 (0.92, 1.95)
Internalizing Problems 1.49 (0.99, 2.25) 1.12 (0.71, 1.75) 1.03 (0.73, 1.45) 1.09 (0.76, 1.56) 1.02 (0.71, 1.48)
Total Problems 1.25 (0.80, 1.93) 1.30 (0.80, 2.11) 1.02 (0.71, 1.48) 1.29 (0.87, 1.91) 0.99 (0.67, 1.47)
ADH Problems 1.78 (0.36, 8.78) 0.91 (0.15, 5.66) 0.55 (0.11, 2.67) 0.98 (0.21, 4.56) 0.46 (0.08, 2.74)
Aggressive Behaviour 1.12 (0.53, 2.39) 1.84 (0.83, 4.07) 1.45 (0.77, 2.73) 1.31 (0.66, 2.63) 1.41 (0.75, 2.68)
Anxious/Depressed 1.55 (0.64, 3.78) 1.64 (0.63, 4.27) 2.56* (1.00, 6.57) 1.14 (0.50, 2.59) 2.48 (0.97, 6.34)
Anxiety Problems 1.42 (0.78, 2.57) 1.06 (0.55, 2.05) 1.61 (0.94, 2.74) 1.19 (0.69, 2.08) 1.59 (0.93, 2.72)
Affective Problems 1.05 (0.66, 1.66) 1.08 (0.65, 1.81) 0.91 (0.61, 1.34) 1.18 (0.79, 1.78) 0.92 (0.60, 1.40)
Somatic Complaints 1.11 (0.64, 1.93) 0.73 (0.39, 1.34) 1.19 (0.75, 1.88) 1.02 (0.64, 1.63) 1.08 (0.66, 1.77)
PD Problems 1.32 (0.79, 2.24) 1.24 (0.71, 2.16) 1.53 (0.97, 2.40) 1.14 (0.72, 1.81) 1.46 (0.92, 2.32)
Withdrawn 1.17 (0.59, 2.34) 1.08 (0.52, 2.25) 1.25 (0.70, 2.24) 1.34 (0.71, 2.52) 1.05 (0.58, 1.93)
Attention Problems 1.58 (0.90, 2.79) 1.71 (0.89, 3.27) 1.57 (0.94, 2.62) 0.85 (0.50, 1.47) 1.46 (0.87, 2.47)

All models are adjusted for urinary creatinine, family income, child sex, and Full-Scale Intelligence Quotient (FSIQ).

a

μg/L.

b

μmol/L.

*

Raw p-value < 0.05.

**

q < 0.10.

***

q < 0.05.